Influence of a rapid change of left ventricular dimensions on the echocardiographic measurement of left ventricular mass by the Penn convention

Journal of Hypertension

Volumn 17, Issue 9, 1999, Pages 1323-1328

  Lantelme, Pierre ^a   Bouchayer, Damien ^a   Gayet, Christian ^a   Lievre, Michel ^b   Gessek, Jacek ^a   Milon, Hugues ^a  

^a CROIX ROUSSE HOSPITAL   (France)

^b Service de Pharmacologie Clinique   (France)

Author keywords

Cardiac hypertrophy; Hypertension; Nitroglycerin

Indexed keywords

CORONARY VASODILATING AGENT; GLYCERYL TRINITRATE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DOUBLE BLIND PROCEDURE; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE SIZE; HEART VENTRICLE SEPTUM; HUMAN; HUMAN EXPERIMENT; MALE; MEASUREMENT; NORMAL HUMAN; OBSERVER VARIATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY;

EID: 0032750439     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199917090-00013     Document Type: Article

References (22)

1. 1 Kannel WB, Gordon T, Castelli WP, Margolis JR. Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. Ann Intern Med 1970; 72:813-822.
2. 2 Troy BL, Pombo J, Rackley CE. Measurement of left ventricular wall thickness and mass by echocardiography. Circulation 1972; 40:602-611.
3. 3 Crow RS, Prineas RJ, Rautaharju P, Hannan P, Liebson PR. Relation between electrocardiography and echocardiography for left ventricular mass in mild systemic hypertension (results from treatment of mild hypertension study). Am J Cardiol 1995; 75:1233-1238.
4. 4 Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med 1990; 322:1561-1566.
5. 5 Gottdiener JS, Reda DJ, Massie BM, Materson BJ, Williams DW, Anderson RJ. Effects of single-drug therapy on reduction of ventricular mass in mild to moderate hypertension. Circulation 1997; 95:2007-2014.
6. 6 Lièvre M, Guéret P, Gayet C, Roudaut R, Haugh MC, Delair S, et al. Ramipril-induced regression of left ventricular hypertrophy in treated hypertensive individuals. Hypertension 1995; 25:92-97.
7. 7 Dahlöf B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies. Am J Hypertens 1992; 5:95-110.
8. 8 Devereux RB, Agabiti-Rosei E, Dahlöf B, Gosse P, Hahn RT, Okin PM, et al. Regression of left ventricular hypertrophy as a surrogate end-point for morbid events in hypertension treatment trials. J Hypertens 1996; 14:S95-S102.
9. 9 De Simone G, Ganau A, Verdecchia P, Devereux RB. Echocardiography in arterial hypertension: when, why, and how? J Hypertens 1994; 12:1129-1136.
10. 10 The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 157:2413-2445.
11. 11 Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Circulation 1977; 55:613-618.
12. 12 Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57:450-458.
13. 13 Devereux RB, Koren MJ, De Simone G, Okin PM, Kligfield P. Methods for detection of left ventricular hypertrophy: application to hypertensive heart disease. Eur Heart J 1993; 14 (suppl. D):8-15.
14. 14 Wallerson DC, Devereux RB. Reproducibility of echocardiographic left ventricular measurements. Hypertension 1987; 9 (suppl. 2):6-18.
15. 15 Fermanian J. Mesure de l'accord entre deux juges: cas quantitatif. Rev Epidemiol Sante Publique 1984; 32:408-413.
16. 16 Gopal AS, Keller AM, Shen Z, Sapin PM, Schroeder KM, King DL Jr, et al. Three-dimensional echocardiography: in vitro and in vivo validation of left ventricular mass and comparison with conventional echocardiographic methods. J Am Coll Cardiol 1994; 24:504-513.
17. 17 Gottdiener JS, Livengood SV, Meyer P. Chase GA. Should echocardiography be performed to assess effects of antihypertensive therapy? Test-retest reliability of echocardiography for measurement of left ventricular mass and function. J Am Coll Cardiol 1995; 25:424-430.
18. 18 Wei JY, Reid PR. Relation of time course of plasma nitroglycerin levels to echocardiographic, arterial pressure and heart rate changes after sublingual administration of nitroglycerin. Am J Cardiol 1981; 48:778-782.
19. 19 Harnett JD, Murphy B, Collingwood P, Purchase L, Kent G, Parfrey PS. The reliability and validity of echocardiographic measurement of left ventricular mass index in hemodialysis patients. Nephron 1993; 65:212-214.
20. 20 Harnett JD, Parfrey PS, Gault MP, Barre PE, Guttmann RD. Left ventricular hypertrophy in endstage renal disease. Nephron 1988; 48:107-115.
21. 21 Ditchey RV, Schuler G, Peterson KL. Reliability of echocardiographic and electrocardiographic parameters in assessing serial changes in left ventricular mass. Am J Med 1981; 70:1042-1050.
22. 22 Neaton JD, Grimm RH, Prineas RJ, Stamler J, Grandits GA, Elmer PJ, et al. Treatment of Mild Hypertension Study. Final results. JAMA 1993; 270:713-724.